Clinique De Flandre
- Address
- 300 Rue Des Forts, 59210 Coudekerque Branche, France
Anal Squamous Cell Carcinoma Research
The oncology department at Clinique De Flandre is conducting a study on locally advanced anal squamous cell carcinoma to determine whether adding induction chemotherapy improves two‑year disease‑free survival.
- Induction chemotherapy followed by chemoradiotherapy
- Standard chemoradiotherapy alone
- Randomized phase III design
- Focus on disease‑related event‑free survival
Positive outcomes could shift treatment guidelines for patients with T3‑4 or N1 disease, offering a more effective therapeutic sequence.
Metastatic Oeso‑Gastric Adenocarcinoma Studies
A separate trial evaluates a novel drug combination to extend overall survival in individuals with metastatic oeso‑gastric adenocarcinoma.
- Combination of trifluridine/tipiracil plus fruquintinib
- Trifluridine/tipiracil alone as control
- Overall survival as primary endpoint
- Randomized phase III methodology
Findings may provide a new line of therapy for patients whose disease has progressed after standard treatments.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 27 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinique De Flandre
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Digital Symptom Monitoring in Patients with Advanced Clear-Cell Renal Carcinoma Treated with Cabozantinib and Nivolumab | Centre Francois Baclesse | Phase III | Recruiting | Jul 2025 | — |
IMP list
lock Showing 1 of 27 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Capecitabine | 2 | Unknown | 2024-02-26 | 2024-07-30 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.